Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
2018 · Annals of the Rheumatic Diseases · 88 citations
https://doi.org/10.1136/annrheumdis-2017-211568